Are OPCH, PCRX, RXO, BOLD Obtaining Fair Deals for their Shareholders?
Halper Sadeh LLC, an investor rights law firm, announced it is investigating Boundless Bio's merger with Serapha Bio for potential securities-law violations and fiduciary breaches. Boundless Bio shareholders are expected to own approximately 3.7% of the combined company upon closing, and the firm is soliciting shareholders to contact it on a contingent-fee basis.
Key figures
- Rxo deal price
- $17.25 per share in cash and 0.0856 shares of C.H. Robinson stock
- Opch deal price
- $32.05 per share
- Pcrx deal price
- $36.50 per share in cash
- Bold combined ownership pct
- approximately 3.7%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.